Edenred Shares Fall 2.5% at the Close of January 20, 2026

Financial Operations and Analyst Recommendations

The group raised 500 million euros through a bond issue at the beginning of January, with a coupon of 3.75% and maturing in 2033, aimed particularly at refinancing debt due in March 2026. This operation, oversubscribed more than three times with a demand of 1.6 billion euros, demonstrates the confidence of institutional investors in Edenred's financial solidity. Regarding analyst recommendations, Alphavalue lowered its price target from 40.60 to 29.90 euros on January 13, while maintaining a 'buy' rating. Morgan Stanley had already reduced its target from 42 to 33 euros in mid-December, maintaining an 'overweight' recommendation. These adjustments reflect a revision of expectations, but the potential for upside remains significant compared to the current price, with a gap of nearly 74% for Alphavalue and 92% for Morgan Stanley, reflecting an attractive valuation despite uncertainties.

Technical Perspective

From a technical standpoint, Edenred is now trading below all its key moving averages. The price is below the 50-day moving average (18.77 euros) and even more so below the 200-day average (23.71 euros), confirming a fundamental downward trend. The RSI at 39 indicates that the stock is neither overbought nor oversold, but it remains under pressure with no immediate sign of reversal. The key support level to watch is at 17.60 euros, a level the stock breached during the session before closing slightly above at 17.195 euros. A sustained break below this threshold could exacerbate the correction. Conversely, a resistance is forming around 19.05 euros, crossing this zone would require a resurgence of upward momentum. The one-month volatility at 6.68% and an ATR of 0.26 reflect measured daily variations, in a context where investors are awaiting the annual results scheduled for February 24.